These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 11786578)

  • 1. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.
    Ahles TA; Saykin AJ; Furstenberg CT; Cole B; Mott LA; Skalla K; Whedon MB; Bivens S; Mitchell T; Greenberg ER; Silberfarb PM
    J Clin Oncol; 2002 Jan; 20(2):485-93. PubMed ID: 11786578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy.
    Ahles TA; Saykin AJ; Noll WW; Furstenberg CT; Guerin S; Cole B; Mott LA
    Psychooncology; 2003 Sep; 12(6):612-9. PubMed ID: 12923801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
    Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
    Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.
    van Dam FS; Schagen SB; Muller MJ; Boogerd W; vd Wall E; Droogleever Fortuyn ME; Rodenhuis S
    J Natl Cancer Inst; 1998 Feb; 90(3):210-8. PubMed ID: 9462678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
    Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
    J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.
    Jim HS; Phillips KM; Chait S; Faul LA; Popa MA; Lee YH; Hussin MG; Jacobsen PB; Small BJ
    J Clin Oncol; 2012 Oct; 30(29):3578-87. PubMed ID: 22927526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing a novel account of the dissociation between self-reported memory problems and memory performance in chemotherapy-treated breast cancer survivors.
    Paquet L; Verma S; Collins B; Chinneck A; Bedard M; Song X
    Psychooncology; 2018 Jan; 27(1):171-177. PubMed ID: 28129471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma.
    Fliessbach K; Urbach H; Helmstaedter C; Pels H; Glasmacher A; Kraus JA; Klockgether T; Schmidt-Wolf I; Schlegel U
    Arch Neurol; 2003 Apr; 60(4):563-8. PubMed ID: 12707070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
    Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
    Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive effects of chemotherapy in breast cancer patients: a dose-response study.
    Collins B; MacKenzie J; Tasca GA; Scherling C; Smith A
    Psychooncology; 2013 Jul; 22(7):1517-27. PubMed ID: 22936651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors.
    Kesler SR; Blayney DW
    JAMA Oncol; 2016 Feb; 2(2):185-92. PubMed ID: 26633037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive deficits in Korean women treated with chemotherapy for breast cancer.
    Jung MS; Cimprich B
    Cancer Nurs; 2014; 37(3):E31-42. PubMed ID: 23945143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Chemobrain' in breast carcinoma?: a prologue.
    Wefel JS; Lenzi R; Theriault R; Buzdar AU; Cruickshank S; Meyers CA
    Cancer; 2004 Aug; 101(3):466-75. PubMed ID: 15274059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
    Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
    J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychologic and neuropsychologic impact of autologous bone marrow transplantation.
    Ahles TA; Tope DM; Furstenberg C; Hann D; Mills L
    J Clin Oncol; 1996 May; 14(5):1457-62. PubMed ID: 8622059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of memory deficits following chemotherapy in breast cancer survivors: evidence from the doors and people test.
    Prokasheva S; Faran Y; Cwikel J; Geffen DB
    J Psychosoc Oncol; 2011; 29(5):499-514. PubMed ID: 21882931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.
    Schilder CM; Eggens PC; Seynaeve C; Linn SC; Boogerd W; Gundy CM; Beex LV; Van Dam FS; Schagen SB
    Acta Oncol; 2009; 48(1):76-85. PubMed ID: 18777410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life of long-term survivors of breast cancer and lymphoma treated with standard-dose chemotherapy or local therapy.
    Ahles TA; Saykin AJ; Furstenberg CT; Cole B; Mott LA; Titus-Ernstoff L; Skalla K; Bakitas M; Silberfarb PM
    J Clin Oncol; 2005 Jul; 23(19):4399-405. PubMed ID: 15994149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study.
    Jenkins V; Shilling V; Fallowfield L; Howell A; Hutton S
    Psychooncology; 2004 Jan; 13(1):61-6. PubMed ID: 14745746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer.
    Wefel JS; Saleeba AK; Buzdar AU; Meyers CA
    Cancer; 2010 Jul; 116(14):3348-56. PubMed ID: 20564075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.